Thirty-five of them, who presented with systolic HF and were not eligible for HTx due to RFPH, were included in the study (31 men aged ± years). In all the patients sildenafil was introduced and uptitrated to a maximal tolerated dose in addition to optimal medical therapy. Patients were assessed at 3–6 months intervals. |